You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Statins and COVID-19: What We Know and Where We’re Going

  • Authors: Joseph Saseen, PharmD, FNLA; Behnood Bikdeli, MD, MS; Steven Grinspoon, MD
  • CME / ABIM MOC / CE Released: 6/25/2021
  • Valid for credit through: 6/25/2022, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for cardiologists and primary care physicians.

The goal of this activity is to improve awareness of importance of statin therapy in the era of COVID-19.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Current meta-analysis data demonstrating impact of statin therapy on COVID-19 outcomes
    • Ongoing trials examining effect of statin therapy on COVID-19-related outcomes 
    • Role of inflammation in COVID-19 infection and progression 
    • Impact of statin therapy on inflammation


As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Joseph Saseen, PharmD, FNLA

    Professor and Associate Dean for Clinical Affairs
    Skaggs School of Pharmacy and Pharmaceutical Sciences
    Professor of Family Medicine
    University of Colorado Anschutz Medical Campus
    Aurora, Colorado
    President, National Lipid Association


    Disclosure: Joseph Saseen, PharmD, FNLA, has no relevant financial relationships.


  • Behnood Bikdeli, MD, MS

    Cardiovascular Medicine Division,
    Brigham and Women’s Hospital, Harvard Medical School
    Center for Outcomes Research and Evaluation,
    Yale University School of Medicine
    Cardiovascular Research Foundation
    Boston, Massachussetts


    Disclosure: Behnood Bikdeli, MD, MS, has the following relevant financial relationships:
    Other: Consulting expert, on behalf of the plaintiff, for litigation related to two specific brand models of IVC filters

  • Steven Grinspoon, MD

    Professor of Medicine,
    Harvard Medical School
    Chief, Metabolism Unit,
    MGH Endowed Chair in Neuroendocrinology and Metabolism
    Director, Nutrition Obesity Research Center at Harvard
    Massachusetts General Hospital
    Boston, Massachussetts


    Disclosure: Steven Grinspoon, MD, has the following relevant financial relationships:
    Advisor or consultant for: Theratechnologies
    Grants for clinical research from: Gilead; KOWA; Theratechnologies; Viiv


  • Joy P. Marko, MS, APN-C, CCMEP

    Senior Medical Education Director, Medscape, LLC 


    Disclosure: Joy P. Marko, MS, APN-C, CCMEP, has disclosed no relevant financial relationships.  

CME/CE Reviewer/Nurse Planner

  • Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) ( 0.050 CEUs) (Universal Activity Number: JA0007105-0000-21-401-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Statins and COVID-19: What We Know and Where We’re Going

Authors: Joseph Saseen, PharmD, FNLA; Behnood Bikdeli, MD, MS; Steven Grinspoon, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 6/25/2021

Valid for credit through: 6/25/2022, 11:59 PM EST


Educational Impact Challenge

The goal of this activity is to improve awareness of importance of statin therapy in the era of COVID-19.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print